KLF2 and breast cancer: To understand why, despite the low levels of miR-126 observed, some miR-126 targets were significantly downregulated in BC (Supplementary Figure S5), we focused on EBF1/ETS2/KLF2-interacting TFs identified via STRING analysis (Figure 7a).